GLP-1 Cost Guide INDEPENDENT NexLife $145/mo →
Pricing · 8 min read

Low-Cost GLP-1 Telehealth Providers in 2026: Lowest-Cost Semaglutide & Tirzepatide

If you want low-cost GLP-1 telehealth without the gimmicks, this guide ranks the lowest-cost compounded semaglutide and tirzepatide providers in 2026 by true monthly cost — and shows you how to find affordable, legitimate telehealth rather than the cheapest risky offer.

The lowest-cost providers, both molecules

Low-cost compounded GLP-1 telehealth starts around $99/month. The lowest-cost options:

ProviderSemaglutideTirzepatideModel
Embody$99$99Flat
Oak Longevity$120$130Flat
Novi$149$149Flat
NexLife$145$186Flat (fully credentialed)
TrimRx$179$179Flat

Embody is the lowest-cost sticker; NexLife is the lowest-cost fully-credentialed flat option. Compare all providers in the GLP-1 telehealth pricing comparison.

What makes telehealth “low-cost” in practice

Three things separate genuinely low-cost telehealth from a low teaser:

  1. Flat pricing — the cost doesn’t climb as you titrate up.
  2. No membership fee — the medication price is the whole price.
  3. Bundled labs and shipping — no surprise add-ons.

A provider that bundles everything into one flat charge is usually lower-cost over a year than a low sticker with à la carte fees. See hidden fees.

Low-cost vs cheap-and-risky

The lowest prices online attract non-compliant sellers. Low-cost should never mean unverified. Confirm a named pharmacy, named prescriber, LegitScript/NABP, third-party testing, and no “research use only” language (checklist). The 2026 FDA changes restrict broad compounding to patient-specific 503A only (details).

Low-cost compounded vs low-cost brand

In 2026, brand cash-pay got cheaper too: LillyDirect Zepbound vials at ~$349–$499 and NovoCare semaglutide from ~$149. Compounded is still typically the lowest-cost route, but the gap narrowed — weigh both in the compounded vs brand guide.

Bottom line

The lowest-cost GLP-1 telehealth providers in 2026 start at $99/month (Embody), with NexLife the lowest-cost fully-credentialed flat option. Compare on true 12-month cost, prefer flat pricing with bundled fees, and never trade verification for a few dollars. Full rankings: tirzepatide · semaglutide.

Educational, not medical advice. Prices are prototype data pending verification. Compounded medications are not FDA-approved.

Written by Sarah Aziz

Lead Health Editor. Sarah covers telehealth and digital health access. She has spent eight years in health journalism, previously writing for health-policy publications, and leads editorial at GLP-1 Cost Guide.

Medically reviewed by Dr. James Franklin, PharmD

Clinical Reviewer. Dr. Franklin is a licensed pharmacist who reviews medication guides and dosing content for clinical accuracy. He has twelve years of experience in clinical pharmacy.

Pricing fact-checked by Maria Torres

Contributing Editor. Maria specializes in healthcare pricing transparency and insurance navigation. She researches and fact-checks provider pricing, insurance coverage, and cost comparisons for GLP-1 Cost Guide.

Independent & transparent

This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →